Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-05-02 8:23 pm Purchase | 13G | Vallon Pharmaceuticals, Inc. VLON | Altium Capital Management LP | 1,269,210 9.99% | 1,269,210![]() (New Position) | View |
2023-04-26 5:18 pm Purchase | 13G | Marpai, Inc. MRAI | Altium Capital Management LP | 1,805,327 6.2% | 1,805,327![]() (New Position) | View |
2023-02-14 4:51 pm Unchanged | 13G | Xtant Medical Holdings, Inc. XTNT | Altium Capital Management LP | 6,497,918 5.7% | 0 (Unchanged) | View |
2023-02-14 3:59 pm Unchanged | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LP | 1,355,372 4.95% | 0 (Unchanged) | View |
2023-02-14 2:44 pm Sale | 13G | HyreCar Inc. HYRE | Altium Capital Management LP | 1,688,120 5.6% | -48,795![]() (-2.81%) | View |
2023-02-14 2:35 pm Unchanged | 13G | Muscle Maker, Inc. GRIL | Altium Capital Management LP | 2,888,085 4.99% | 0 (Unchanged) | View |
2023-02-14 12:35 pm Sale | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LP | 0 0% | -333,333![]() (Position Closed) | View |
2023-02-14 12:26 pm Sale | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LP | 0 0% | -3,350,000![]() (Position Closed) | View |
2022-12-21 2:12 pm Purchase | 13G | Astria Therapeutics, Inc. ATXS | Altium Capital Management LP | 1,355,372 5.2% | 1,355,372![]() (New Position) | View |
2022-11-17 5:08 pm Purchase | 13G | NeuroBo Pharmaceuticals, Inc. NRBO | Altium Capital Management LP | 333,333 7.7% | 333,333![]() (New Position) | View |
2022-11-08 7:44 pm Purchase | 13G | HyreCar Inc. HYRE | Altium Capital Management LP | 1,736,915 5.8% | 1,736,915![]() (New Position) | View |
2022-02-14 3:09 pm Sale | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LP | 3,350,000 9.99% | -644,302![]() (-16.13%) | View |
2022-02-14 3:06 pm Purchase | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Altium Capital Management LP | 4,276,252 4.99% | 3,037,823![]() (+245.30%) | View |
2022-02-14 2:37 pm Purchase | 13G | Palisade Bio, Inc. PALI | Altium Capital Management LP | 3,994,302 4.99% | 2,668,410![]() (+201.25%) | View |
2022-02-14 2:30 pm Sale | 13G | Regulus Therapeutics Inc. RGLS | Altium Capital Management LP | 1,729,780 2.1% | -1,500,000![]() (-46.44%) | View |
2022-02-14 10:16 am Unchanged | 13G | urban-gro, Inc. UGRO | Altium Capital Management LP | 0 0% | 0 (Unchanged) | View |
2022-02-14 09:53 am Unchanged | 13G | Ocuphire Pharma, Inc. OCUP | Altium Capital Management LP | 2,678,883 4.99% | 0 (Unchanged) | View |
2022-02-14 09:40 am Sale | 13G | Timber Pharmaceuticals, Inc. TMBR | Altium Capital Management LP | 5,878,414 4.99% | -3,000,000![]() (-33.79%) | View |
2022-02-14 06:16 am Sale | 13G | electroCore, Inc. ECOR | Altium Capital Management LP | 0 0% | -5,000,000![]() (Position Closed) | View |
2022-02-14 06:11 am Purchase | 13G | Unicycive Therapeutics, Inc. UNCY | Altium Capital Management LP | 176,000 1.2% | 176,000![]() (New Position) | View |